---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-023648"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T19:02:09.488001+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CFO Nirav Jhaveri departs Opus Genetics; Amy Rabourn appointed interim principal financial officer

## Summary
- CFO Nirav Jhaveri terminated without cause on June 25, 2025; no disagreement with auditors or management.
- Jhaveri eligible for severance per employment agreement subject to separation release.
- Amy Rabourn, SVP of Finance, serves as principal financial and accounting officer until successor appointed.
- Rabourn has 20+ years finance experience, CPA, previously at Gemphire and Pfizer.

## SEC filing metadata
- accession: 0001140361-25-023648
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000114036125023648/0001140361-25-023648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000114036125023648/ef20051087_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-023648
- JSON: https://secwatch.observer/filing/0001140361-25-023648.json
- Plain text: https://secwatch.observer/filing/0001140361-25-023648.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.